Literature DB >> 7845801

Four chamber pacing in dilated cardiomyopathy.

S Cazeau1, P Ritter, S Bakdach, A Lazarus, M Limousin, L Henao, O Mundler, J C Daubert, J Mugica.   

Abstract

A 54-year-old man received a four chamber pacing system for severe congestive heart failure (NYHA functional Class IV). His ECG showed a left bundle branch block (200-msec QRS duration) with 200-msec PR interval, normal QRS axis, and 90-msec interatrial interval. An acute hemodynamic study with insertion of four temporary leads was performed prior to the implant, which demonstrated a significant increase in cardiac output and decrease of pulmonary capillary wedge pressure. A permanent pacemaker was implanted based on the encouraging results of the acute study. The right chamber leads were introduced by cephalic and subclavian approaches. The left atrium was paced with a coronary sinus lead, Medtronic SP 2188-58 model. An epicardial Medtronic 5071 lead was placed on the LV free wall. The four leads were connected to a standard bipolar DDD pacemaker, Chorus 6234. The two atrial leads were connected via a Y-connector to the atrial channel of the pacemaker with a bipolar pacing configuration. The two ventricular leads were connected in a similar fashion to the ventricular channel of the device. The right chamber leads were connected to the distal poles. The left chamber leads were connected to the proximal poles of the pacemaker. Six weeks later, the patient's clinical status improved markedly with a weight loss of 17 kg and disappearance of peripheral edema. His functional class was reduced to NYHA II. Four chamber pacing is technically feasible. In patients with evidence of interventricular dyssynchrony, this original pacing mode probably provides a mechanical activation sequence closer to the natural one.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1994        PMID: 7845801     DOI: 10.1111/j.1540-8159.1994.tb03783.x

Source DB:  PubMed          Journal:  Pacing Clin Electrophysiol        ISSN: 0147-8389            Impact factor:   1.976


  57 in total

1.  Six year experience of transvenous left ventricular lead implantation for permanent biventricular pacing in patients with advanced heart failure: technical aspects.

Authors:  C Alonso; C Leclercq; F R d'Allonnes; D Pavin; F Victor; P Mabo; J C Daubert
Journal:  Heart       Date:  2001-10       Impact factor: 5.994

2.  Biventricular pacing in end-stage heart failure improves functional capacity and left ventricular function.

Authors:  P F Bakker; H W Meijburg; J W de Vries; M M Mower; A C Thomas; M L Hull; E O Robles De Medina; J J Bredée
Journal:  J Interv Card Electrophysiol       Date:  2000-06       Impact factor: 1.900

3.  Early and late QRS morphology and width in biventricular pacing: relationship to lead site and electrical remodeling.

Authors:  Renato Ricci; Carlo Pignalberi; Gerardo Ansalone; Enzo Jannone; Maria Vittoria Vaccaro; Alessandra Denaro; Sergio Cavaglià; Massimo Santini
Journal:  J Interv Card Electrophysiol       Date:  2002-07       Impact factor: 1.900

Review 4.  Window to the heart: the value of a native and paced QRS duration. Current perspective and review.

Authors:  Himanshu H Shukla; Erskine A James; John A Schutz; Benjamin F Lloyd; Greg C Flaker
Journal:  J Interv Card Electrophysiol       Date:  2003-12       Impact factor: 1.900

5.  Left ventricular pacing should be considered when biventricular pacing worsens heart failure: left ventricular pacing instead of biventricular pacing?

Authors:  Syed Y Ahsan; Matthew W Fittall; Aerakondal B Gopalamurugan; James W McCready; Laurence Nunn; Anthony W Chow
Journal:  J Interv Card Electrophysiol       Date:  2011-09-21       Impact factor: 1.900

Review 6.  Role of resynchronisation therapy and implantable cardioverter defibrillators in heart failure.

Authors:  S Ellery; L Williams; M Frenneaux
Journal:  Postgrad Med J       Date:  2006-01       Impact factor: 2.401

7.  Biventricular pacing in a patient with severe congestive heart failure.

Authors:  Hiroyuki Tanaka; Kaoru Okishige; Mikiko Murakami; Takeshi Someya; Hirokuni Arai; Makoto Sunamori
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2002-07

Review 8.  Cardiac resynchronization therapy.

Authors:  Brian T Schuler; Angel R León
Journal:  Curr Cardiol Rep       Date:  2005-09       Impact factor: 2.931

9.  Cardiac Resynchronization Therapy for Advanced Heart Failure.

Authors:  Philip B. Adamson; William T. Abraham
Journal:  Curr Treat Options Cardiovasc Med       Date:  2003-08

Review 10.  Devices in the management of advanced, chronic heart failure.

Authors:  William T Abraham; Sakima A Smith
Journal:  Nat Rev Cardiol       Date:  2012-12-11       Impact factor: 32.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.